India’s leading drugmaker by revenue, Sun Pharmaceutical Industries, has received regulatory approval to manufacture and sell semaglutide, the generic version of the blockbuster weight-loss drug ...

By Kashish Tandon and Rishika Sadam Jan 23 (Reuters) - Sun Pharmaceutical Industries, India's top drugmaker by revenue, said on Friday it has received a regulatory nod to manufacture and sell ...

Sun ‍Pharmaceutical Industries , India's top ​drugmaker by revenue, said ‌on Friday it has ​received regulatory approval to manufacture and sell the generic version of blockbuster weight-loss drug ...

Sun Pharmaceutical Industries , India's top drugmaker by revenue, said on Friday it has received regulatory approval to manufacture and sell the generic version of blockbuster weight-loss drug Wegovy ...

A consumer pricing framework for 'Cheapest Compounded Semaglutide,' 'Cheapest Compounded Semaglutide Online,' and 'Cheapest ...

Researchers say that a different weight loss drug is taking the US by storm, and knocking Ozempic off its pedestal.

With one in eight Americans now using GLP-1 medications like Ozempic and Wegovy, fast food restaurants are introducing ...

The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

With more Black women over 40 using GLP-1s, we break down the risks when it comes to micro-dosing the drug for menopausal weight gain.

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, ...